Medical technology company Monivent has appointed Tobias Tullberg as its new CEO, effective 4 January 2027, according to a press release. He succeeds co-founder Maria Lindqvist, who will take on a new role focusing on product development and clinical collaborations.Tullberg most recently served as CEO of AprioMed and has nearly 30 years of experience in medical technology. The management change comes as Monivent transitions from development and regulatory work to commercialisation and international expansion ahead of a planned European launch of Neo100 together with Dräger."Now that we are preparing for the market launch in Europe and the next step in Monivent's international development, we believe that Tobias's extensive experience in medical technology and business is an excellent fit for the company," comments Chairman of the Board John Haurum.